Hiroshi Obata

4.8k total citations · 1 hit paper
106 papers, 3.8k citations indexed

About

Hiroshi Obata is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Hiroshi Obata has authored 106 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 39 papers in Hepatology and 17 papers in Molecular Biology. Recurrent topics in Hiroshi Obata's work include Liver Disease Diagnosis and Treatment (25 papers), Hepatitis B Virus Studies (21 papers) and Liver Disease and Transplantation (12 papers). Hiroshi Obata is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Hepatitis B Virus Studies (21 papers) and Liver Disease and Transplantation (12 papers). Hiroshi Obata collaborates with scholars based in Japan, United States and Pakistan. Hiroshi Obata's co-authors include Kunio Okuda, Yukio Nakajima, Nobuo Okazaki, Toshio Ohtsuki, Kunihiko Ohnishi, Masahiko Tomimatsu, Hiroshi Hasegawa, Hiroaki Okuda, Yoji Motoike and Yasuhiko Kubo and has published in prestigious journals such as The Lancet, Gastroenterology and Hepatology.

In The Last Decade

Hiroshi Obata

102 papers receiving 3.6k citations

Hit Papers

Natural history of hepatocellular carcinoma and prognosis... 1985 2026 1998 2012 1985 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Obata Japan 26 2.6k 1.7k 873 607 525 106 3.8k
Shigetoshi Fujiyama Japan 29 3.0k 1.2× 2.4k 1.4× 348 0.4× 500 0.8× 295 0.6× 124 4.2k
Ja Kyung Kim South Korea 34 2.5k 1.0× 2.1k 1.2× 800 0.9× 383 0.6× 319 0.6× 149 3.8k
Fukuo Kondo Japan 34 1.8k 0.7× 1.3k 0.8× 1.2k 1.4× 1.1k 1.8× 312 0.6× 140 3.7k
Loreto Boix Spain 29 2.7k 1.0× 1.9k 1.1× 694 0.8× 845 1.4× 810 1.5× 68 4.4k
Kazuhiro Nouso Japan 39 2.5k 1.0× 1.9k 1.1× 819 0.9× 1.1k 1.8× 1.1k 2.1× 221 5.0k
Mary A. Maluccio United States 26 1.7k 0.7× 1.0k 0.6× 1.2k 1.4× 1.1k 1.8× 662 1.3× 77 4.4k
Si Hyun Bae South Korea 40 3.9k 1.5× 2.7k 1.6× 1.1k 1.2× 818 1.3× 672 1.3× 250 5.6k
Kaoru Tsuchiya Japan 30 2.5k 1.0× 2.0k 1.2× 357 0.4× 305 0.5× 256 0.5× 140 3.2k
Katsunori Yoshida Japan 32 1.2k 0.5× 882 0.5× 604 0.7× 782 1.3× 239 0.5× 122 3.6k
David K. Imagawa United States 36 1.7k 0.7× 1.0k 0.6× 2.2k 2.5× 547 0.9× 158 0.3× 131 4.0k

Countries citing papers authored by Hiroshi Obata

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Obata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Obata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Obata more than expected).

Fields of papers citing papers by Hiroshi Obata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Obata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Obata. The network helps show where Hiroshi Obata may publish in the future.

Co-authorship network of co-authors of Hiroshi Obata

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Obata. A scholar is included among the top collaborators of Hiroshi Obata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Obata. Hiroshi Obata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shizuma, Toru, Hiroshi Obata, Etsuko Hashimoto, & Keiko Shiratori. (2003). Relationship between bacteremia and severity of liver dysfunction in patients with liver cirrhosis. Kanzo. 44(12). 641–648. 3 indexed citations
3.
Shizuma, Toru, Hiroshi Obata, Etsuko Hashimoto, Kiyoshi Hasegawa, & Naoaki Hayashi. (2002). Clinical analysis of drug-induced liver injury.. Kanzo. 43(7). 309–315. 1 indexed citations
4.
Shizuma, Toru, Hiroshi Obata, Etsuko Hashimoto, & Naoaki Hayashi. (2002). Clinical analysis of bacterial infections in cirrhotic patients with ascites.. Kanzo. 43(10). 446–452. 3 indexed citations
5.
Ludwig, Jürgen, Etsuko Hashimoto, Hiroshi Obata, & William P. Baldus. (1993). Idiopathic portal hypertension. Hepatology. 17(6). 1157–1162. 28 indexed citations
6.
Ando, Yukio, et al.. (1993). Two cases of fulminant hepatic failure in malignant lymphoma.. Kanzo. 34(10). 819–824. 1 indexed citations
7.
Hashimoto, Etsuko, et al.. (1993). A case of post-infantile giant cell hapatitis with positive of LE cell, antinuclear antibody.. Kanzo. 34(3). 239–243. 2 indexed citations
8.
Hashimoto, Etsuko, et al.. (1993). Liver biopsy features of acute hepatitis C compared with hepatitis A, B, and non‐A, non‐B, non‐C. Liver International. 13(2). 69–73. 25 indexed citations
9.
Kojimahara, Noriko, et al.. (1992). A case report. Middle-aged congenital hepatic fibrosis followed up as idiopathic portal hypertension.. Kanzo. 33(8). 643–648. 1 indexed citations
10.
Nakano, Masayuki, et al.. (1990). A histopathologic study of early hepatocellular carcinoma (HCC): Portal tract invasion and progression to advanced HCC. Kanzo. 31(7). 754–761. 11 indexed citations
11.
Nakanishi, Toshimi, et al.. (1989). Comparison of Effects of Menaquinone-4 and Menaquinone-7 Assessed by Decrease of PIVKA-II Levels in Human Hepatoma Cells in Culture. 63(5). 253–257. 6 indexed citations
12.
Mariyama, Mariko, Kiyozo Kishi, Kozo Nakamura, Hiroshi Obata, & Susumu Nishimura. (1989). Frequency and Types of Point Mutation at the 12th Codon of the c‐Ki‐ras Gene Found in Pancreatic Cancers from Japanese Patients. Japanese Journal of Cancer Research. 80(7). 622–626. 104 indexed citations
13.
Okuda, Hiroaki, et al.. (1988). Production of abnormal prothrombin(PIVKA-II) by human hepatoma cells in culture.. Kanzo. 29(1). 47–51. 3 indexed citations
14.
Komatsu, Tatsuji, Katsumi Yamauchi, Kiyoshi Hasegawa, et al.. (1987). Clinical trial of trans-arterial administration of LAK and IL-2 to patient with hepatocellural carcinoma - Case reports.. Kanzo. 28(4). 477–482. 2 indexed citations
15.
Hashimoto, Etsuko, Toshimi Nakanishi, Takeshi Kurihara, et al.. (1986). Long-term outcome of hepatitis B vaccination and memory of immunization.. Kanzo. 27(10). 1371–1375. 1 indexed citations
16.
Okuda, Hiroaki, Toshimi Nakanishi, Ryuji FURUKAWA, Etsuko Hashimoto, & Hiroshi Obata. (1986). Production of abnormal prothrombin (PIVKA-II) by hepatocellular carcinoma. A clinical and experimental study.. Kanzo. 27(12). 1697–1702. 2 indexed citations
17.
Hashimoto, Etsuko, Hiroshi Obata, Toshimi Nakanishi, et al.. (1985). HLA antigens and anti-HBs response to hepatitis B vaccine.. Kanzo. 26(2). 157–164. 6 indexed citations
18.
Takasaki, Ken, Seiichi Tanaka, Akiko Saito, et al.. (1982). Experiences with hepatic resection of 60 cases of hepatocellular carcinoma. Kanzo. 23(2). 159–164. 2 indexed citations
19.
Tanaka, Seiichi, et al.. (1982). . Kanzo. 23(2). 159–164. 2 indexed citations
20.
Obata, Hiroshi, Naoaki Hayashi, T Hisamitsu, et al.. (1976). Development of Hepatocellular Carcinoma on the Ground of Chronic Liver Diseases. Kanzo. 17(5). 335–347. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026